Bloomington, Indiana, United States Cook Pharmica, LLC appeared to be the Corporate Investor, which was created in 2004. The leading representative office of defined Corporate Investor is situated in the Bloomington. The company was established in North America in United States.
Among the various public portfolio startups of the fund, we may underline Coherus Biosciences Among the most popular fund investment industries, there are Manufacturing, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top amount of exits for fund were in 2014. The important activity for fund was in 2012.
The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Cook Pharmica, LLC, startups are often financed by Medpace, Helix Ventures. The meaningful sponsors for the fund in investment in the same round are Medpace, Lilly Ventures, Helix Ventures. In the next rounds fund is usually obtained by Helix Ventures, Vivo Capital, Viva Capital Advisors.
Related Funds
| Fund Name | Location |
| AstraZeneca | Cambridge, Cambridgeshire, United Kingdom |
| Brait | Central Region, Malta, NA - Malta |
| Huaxing Alpha | New York, New York, United States |
| Inmobiliaria e Inversiones el Coigue | Chile, Santiago Metropolitan Region, Vitacura |
| McConnell Foundation | Canada, Montreal, Quebec |
| MRI Ventures | Kansas City, Missouri, United States |
| Pearl Energy Investments | Dallas, Texas, United States |
| Sumavision | Beijing, Beijing, China |
| Yushan Ventures | Taipei, Taiwan |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Coherus Biosciences | $61M | 01 Jan 2012 | Redwood City, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Coherus Biosciences | $61M | 01 Jan 2012 | Redwood City, California, United States |
